Wilson Therapeutics Company
Wilson Therapeutics focuses on developing novel therapies addressing unmet medical needs in rare diseases.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Stockholm, Stockholms Lan, Sweden
Founded Date:
2012
Employees Number:
11-50
Funding Status:
M&A
Investors Number:
2
Total Funding:
$27.2M
Estimated Revenue:
$10M to $50M
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership